First Allied Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History

First Allied Advisory Services’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$732K	Sell	6,400 -1,711	-21%	-$185K	0.02%	577
2020 Q2	$910K	Sell	8,111 -4,856	-37%	-$516K	0.03%	465
2020 Q1	$1.16M	Buy	12,967 +5,160	+66%	+$506K	0.05%	361
2019 Q4	$845K	Buy	7,807 +4,812	+161%	+$515K	0.03%	535
2019 Q3	$295K	Buy	+2,995	New	+$338K	0.01%	904
2016 Q1	–	Sell	-1,083	Closed	-$205K	–	1140
2015 Q4	$205K	Buy	+1,083	New	+$189K	0.01%	961

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Allied Advisory Services's ALXN Position: Q3 2020 in Review

First Allied Advisory Services reduced its Alexion Pharmaceuticals (ALXN) stake by 21% in Q3 2020, selling an estimated $185K and leaving 6,400 shares worth $732K. The position accounts for 0.02% of the portfolio, ranked #577.

First Allied Advisory Services first reported a position in ALXN in Q4 2015 and has held it in 6 quarters since. The position peaked at $1.16M in Q1 2020. 709 funds tracked by Wall St. Rank hold ALXN as of Q3 2020.

First Allied Advisory Services held 6,400 shares of Alexion Pharmaceuticals worth $732K as of Q3 2020.
First Allied Advisory Services sold 1,711 Alexion Pharmaceuticals shares in Q3 2020, an estimated $185K.
Alexion Pharmaceuticals made up 0.02% of First Allied Advisory Services's portfolio in Q3 2020, its #577 holding.
First Allied Advisory Services first reported a position in Alexion Pharmaceuticals in Q4 2015 and has held it in 6 quarters since.
First Allied Advisory Services's Alexion Pharmaceuticals position peaked at $1.16M in Q1 2020.
709 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.